IHM
Iguana Healthcare Management Portfolio holdings
AUM
$133M
This Quarter Return
+23.92%
1 Year Return
+45.66%
3 Year Return
+127.07%
5 Year Return
–
10 Year Return
–
AUM
$238M
AUM Growth
+$238M
(+31%)
Cap. Flow
+$39M
Cap. Flow
% of AUM
16.39%
Top 10 Holdings %
Top 10 Hldgs %
44.18%
Holding
82
New
31
Increased
11
Reduced
13
Closed
17
Top Buys
| 1 |
Pfizer
PFE
|
$18.3M |
| 2 |
Ultragenyx Pharmaceutical
RARE
|
$7.76M |
| 3 |
AGN
Allergan plc
AGN
|
$7.44M |
| 4 |
iShares Russell 2000 ETF
IWM
|
$6.22M |
| 5 |
ENDP
Endo International plc
ENDP
|
$5.38M |
Top Sells
| 1 |
Biogen
BIIB
|
$13.6M |
| 2 |
Medtronic
MDT
|
$9.03M |
| 3 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$6.13M |
| 4 |
Viatris
VTRS
|
$5.64M |
| 5 |
Amgen
AMGN
|
$5.58M |
Sector Composition
| 1 | Healthcare | 81.93% |
| 2 | Real Estate | 0.91% |
| 3 | Technology | 0.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Pfizer
PFE
$141B
| $20.9M | 8.78% |
600,000
+525,000
| +700% | +$18.3M |
|
2
Esperion Therapeutics
ESPR
$448M
| $18.5M | 7.79% |
200,000
| – | – |
|
|
CELG
3
DELISTED
Celgene Corp
CELG
| $12.7M | 5.33% |
110,000
| – | – |
|
|
4
Ultragenyx Pharmaceutical
RARE
$2.89B
| $10.9M | 4.57% |
175,000
+125,000
| +250% | +$7.76M |
|
5
Gilead Sciences
GILD
$140B
| $9.81M | 4.13% |
100,000
-25,000
| -20% | -$2.45M |
|
|
AGN
6
DELISTED
Allergan plc
AGN
| $7.44M | 3.13% |
+25,000
| New | +$7.44M |
|
|
XLRN
7
DELISTED
Acceleron Pharma Inc.
XLRN
| $6.66M | 2.8% |
175,000
-40,000
| -19% | -$1.52M |
|
|
8
iShares Russell 2000 ETF
IWM
$67B
| $6.22M | 2.62% |
+50,000
| New | +$6.22M |
|
9
Supernus Pharmaceuticals
SUPN
$2.53B
| $6.05M | 2.54% |
500,000
| – | – |
|
10
Puma Biotechnology
PBYI
$254M
| $5.9M | 2.48% |
25,000
+15,000
| +150% | +$3.54M |
|
11
Zimmer Biomet
ZBH
$21B
| $5.88M | 2.47% |
50,000
+25,000
| +100% | +$2.94M |
|
|
AXDX
12
DELISTED
Accelerate Diagnostics
AXDX
| $5.63M | 2.37% |
250,000
+200,000
| +400% | +$4.5M |
|
|
ENDP
13
DELISTED
Endo International plc
ENDP
| $5.38M | 2.26% |
+60,000
| New | +$5.38M |
|
14
Humana
HUM
$36.5B
| $5.34M | 2.25% |
+30,000
| New | +$5.34M |
|
|
ESRX
15
DELISTED
Express Scripts Holding Company
ESRX
| $5.21M | 2.19% |
+60,000
| New | +$5.21M |
|
|
HZNP
16
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $5.19M | 2.18% |
200,000
| – | – |
|
|
STJ
17
DELISTED
St Jude Medical
STJ
| $4.91M | 2.06% |
+75,000
| New | +$4.91M |
|
|
GWPH
18
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $4.56M | 1.92% |
50,000
-10,000
| -17% | -$911K |
|
|
WCG
19
DELISTED
Wellcare Health Plans, Inc.
WCG
| $4.12M | 1.73% |
+45,000
| New | +$4.12M |
|
|
TRNX
20
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $3.93M | 1.65% |
150,000
| – | – |
|
21
Cigna
CI
$80.3B
| $3.88M | 1.63% |
+30,000
| New | +$3.88M |
|
|
AERI
22
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $3.76M | 1.58% |
120,000
-30,000
| -20% | -$940K |
|
23
Cardinal Health
CAH
$35.5B
| $3.61M | 1.52% |
+40,000
| New | +$3.61M |
|
|
IPXL
24
DELISTED
Impax Laboratories, Inc.
IPXL
| $3.52M | 1.48% |
75,000
-25,000
| -25% | -$1.17M |
|
|
CBAY
25
DELISTED
Cymabay Therapeutics
CBAY
| $3.46M | 1.46% |
500,000
+375,000
| +300% | +$2.6M |
|